Resilient transdermal drug-delivery device and compositions...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/159

A61K 9/70 (2006.01) A61K 31/445 (2006.01) A61M 35/00 (2006.01)

Patent

CA 1309021

- 32 - RESILIENT TRANSDERMAL DRUG-DELIVERY DEVICE AND COMPOSITIONS AND DEVICES EMPLOYING FATTY ACID ESTERS/ETHERS OF ALKANEDIOLS AS PERCUTANEOUS ABSORPTION ENHANCERS Abstract A solid state, resilient laminated composite for administering estradiol transdermally consisting of a multiplicity of spaced structural laminas of a resilient elastomer, one of which forms the top of the composite, a viscoelastic hydrophobic polymer lamina containing propylene glycol monolaurate interposed between each structural lamina and a pressure-sensitive adhesive lamina that provides the basal surface of the composite and consists of a blend of a pressure-sensitive adhesive, estradiol, and propylene glycol monolaurate.

555141

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Resilient transdermal drug-delivery device and compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Resilient transdermal drug-delivery device and compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Resilient transdermal drug-delivery device and compositions... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1282186

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.